| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Palvella Therapeutics, Inc. (PVLA) has 3 insiders with recent SEC Form 4 filings, including 10 buys and 0 sells. PVLA is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 187.2K | $22.07M | - | |
| Dir | 47.8K | $5.64M | - | |
| COO | 4.3K | $507.2K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Aug 17, 2017 | Reine Allan | See Remarks | Buy | 65,000 | $4.82 | $313,350.00 | +144.4% | |
| Jun 14, 2016 | Matis Louis | SVP, Chief Development Officer | Buy | 10,000 | $1.70 | $17,037.45 | +479.6% | |
| Jun 13, 2016 | Yoder Stephen S. | President And CEO | Buy | 6,000 | $1.68 | $10,080.00 | New | |
| Jun 13, 2016 | Deptula-Hicks Darlene M | SVP, Chief Financial Officer | Buy | 5,000 | $1.66 | $8,300.00 | New | |
| Jul 6, 2015 | Orbimed Advisors LLC67 | Director, 10% Owner | Buy | 500,000 | $2.75 | $1,375,000.00 | +7.4% | |
| Jul 6, 2015 | Khuong Chau Quang | Director, 10% Owner | Buy | 500,000 | $2.75 | $1,375,000.00 | +7.4% |